Submissions for variant NM_001083962.2(TCF4):c.305-159dup

Total submissions: 1

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute	RCV002472229	SCV002769328	uncertain significance	Pitt-Hopkins syndrome	2020-05-25	criteria provided, single submitter	clinical testing	Based on the classification scheme VCGS_Germline_v1.1.1, this variant is classified as 3B-VUS. Following criteria are met: 0102 - Loss-of-function is a known mechanism of disease for this gene. (N) 0107 - This gene is known to be associated with autosomal dominant disease. (N) 0202 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein function, however is located in an exon that may undergo alternative splicing (exon 1 of 16). NB: Transcript NM_001243232.1 was chosen for analysis because the impact of the variant is predicted to be the most deleterious to the protein. However, in the canonical transcript and other transcripts, this variant is non-coding. (P) 0251 - Variant is heterozygous. (N) 0301 - Variant is absent from gnomAD. (P) 0701 - No comparable variants in this transcript have been reported. (N) 0807 - Variant has not previously been reported in a clinical context. (N) 0905 - No segregation evidence has been identified for this variant. (N) 1007 - No published functional evidence has been identified for this variant. (N) 1208 - Inheritance information for this variant is not currently available. (N) Legend: (P) - Pathogenic, (N) - Neutral, (B) - Benign